Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma

Cancer Research

Volumn 56, Issue 5, 1996, Pages 1037-1042

  Ermak, Gennady ^a   Jennings, Timothy ^a   Robinson, Lawrence ^a   Ross, Jeffrey S ^a   Figge, James ^a,b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN;

ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; EXON; HUMAN; HUMAN TISSUE; METASTASIS; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SPLICING; THYROID CARCINOMA; TUMOR GROWTH;

ALTERNATIVE SPLICING; ANTIGENS, CD44; BASE SEQUENCE; CARCINOMA, PAPILLARY; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; THYROID NEOPLASMS;

EID: 0030044274     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hay, I. Papillary thyroid carcinoma. Endocrinol. Metab. Clin North Am., 19: 545-576, 1990.
2. Oertel, J. E., and LiVolsi, V. A. Pathology of thyroid diseases. In: L. E. Braverman and R. D. Utiger (eds.), Werner and Ingbar's The Thyroid, pp. 603-642. Philadelphia: J B. Lippincott, 1991.
3. Mazzaferri, E. L., and Jhiang, S. M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med., 97: 418-428, 1994.
4. Fagin, J. A. Molecular pathogenesis of human thyroid neoplasms. Thyroid Today, 17: 1-7, 1994.
5. Figge, J., del Rosario, A. D., Gerasimov, G , Dedov, I., Bronstein, M., Troshina, K., Alexandrova, G., Kallakury, B V. S , Bui, H. X , Bratslavsky, G., and Ross, J. S. Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma. Exp Mol. Pathol., 61. 203-211, 1994.
6. Haynes, B. F. Telen, M J., Hale, L. P., and Denning, S. M. CD44 - a molecule involved in leukocyte adherence and T-cell activation. Immunol. Today, 10. 423-428, 1989.
7. Underhill, C. CD44: the hyaluronan receptor. J. Cell Sci., 103: 293-298, 1992.
8. Gunthert, U. CD44: a multitude of isoforms with diverse functions. Curr. Top Microbiol. Immunol , 184: 47-63, 1993.
9. Lesley, J., Hyman, R., and Kincade, P. W. CD44 and its interaction with extracellular matrix. Adv. Immunol., 54: 271-335, 1993.
10. Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., and Seed, B. CD44 is the principal cell surface receptor for hyaluronate. Cell. 61: 1303-1313, 1990.
11. Brown, T A , Bouchard, T., St. John, T., Wayner, E., and Carter, W G. Human keratinocytes express a new CD44 core protein (CD44E) as a heparin-sulfate intrinsic membrane proteoglycan with additional exons. J. Cell Biol., 113: 207-221, 1991.
12. Screaton, G. R., Bell, M V., Jackson, D. G., Cornelis, F. B., Gerth, U., and Bell, J. I. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc. Natl. Acad. Sci. USA, 89: 12160-12164, 1992.
13. Screaton, G. R., Bell, M V., Bell, J. I., and Jackson, D. G The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse pgp-1 (CD44) homing receptor J. Biol. Chem., 268 12235-12238, 1993.
14. Fox, S. B., Fawcett, J., Jackson, D. G., Collins, I., Gatter, K. C , Harris, A. L., Gearing, A., and Simmons, D. L. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res , 54: 4539-4546, 1994
15. Mackay, C. R., Terpe, H-J., Stauder, R., Marston, W. L., Stark, H., and Gunthert, U Expression and modulation of CD44 variant isoforms in humans J. Cell Biol., 124: 71-82, 1994.
16. Ermak, G , Gerasimov, G., Troshina, K., Jennings, T., Robinson, L., Ross, J. S., and Figge, J. Deregulated alternative splicing of CD44 mRNA: transcripts in neoplastic and nonneoplastic lesions of the human thyroid Cancer Res., 55: 4594-4598, 1995.
17. Gunthert, U , Hofmann, M , Rudy, W , Reber, S , Zoller, M., Haussmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65: 13-24, 1991.
18. Arch, R , Wirth, K., Hofmann, M., Ponta, H., Matzku, S., Herrlich, P., and Zoller, M. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science (Washington DC), 257: 682-685, 1992.
19. Seiter, S , Arch, R., Reber, S., Komitowski, D., Hofmann, M., Ponta, H., Herrlich, P , Matzku, S , and Zoller, M. Prevention of tumor metastasis formation by anti-variant CD44. J. Exp Med , 177: 443-455, 1993.
20. Hofmann, M , Rudy, W., Zoller, M., Tolog, C., Ponta, H., Herrlich, P., and Gunthert, U. CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor lines Cancer Res., 51: 5292-5297, 1991
21. Rudy, W , Hofmann, M., Schwartz-Albiez, R., Zoller, M., Heider, K. H., Ponta, H., and Herrlich, P. Two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. Cancer Res., 53: 1262-1268, 1993.
22. Dougherty, G J., Dougherty, S T , Eaves, C J , and McBride, W. H. Expression of human CD44R1 enhances the metastatic capacity of murine fibrosarcoma cells Proc. Am. Assoc. Cancer Res., 33: 35, 1992.
23. Matsumura, Y , and Tarin, D. Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet, 340: 1053-1058, 1992.
24. TaKaRa Shuzo Company. TaKaRa Technical Bulletin TaKaRa LA PCR Guide Otsu, Japan, 1995.
25. Barnes, W. M. PCR amplification of up to 35-kb DNA with high fidelity and high yield from lambda bacteriophage templates. Proc. Natl. Acad. Sci. USA, 91: 2216-2220, 1994
26. Cheng, S., Fockler, C., Barnes, W. M , and Higuchi, R. Effective amplification of long targets from cloned inserts and human genomic DNA. Proc. Natl. Acad. Sci USA, 91: 5695-5699, 1994.
27. Robbins, M , and McKinney, M. Transcriptional regulation of neuromodulin (GAP-43) in mouse neuroblastoma clone N1E-115 as evaluated by the RT/PCR method. Brain Res. Mol Brain Res , 13: 83-92, 1992.
28. Shtivelman, E , and Bishop, J. M. Expression of CD44 is repressed in neuroblastoma cells. Mol. Cell. Biol., 11. 5446-5453, 1991.
29. Mazzaferri, E L. In Braverman, L. E , and Utiger, R. D (eds.). Werner and Ingbar's The Thyroid. Ed 6, p 1142. Philadelphia: J. B. Lippincott Co, 1991.